Such changes could aggravate depletion of cardiac energy resources thus contributing to myocardial injury, cell death and heart failure progression, and are consistent with the known beneficial effects on cardiac stress resistance that occur with CaMKII inhibition [33–35, 37–39]. The gene discussed is CAMK2G; the disease is heart failure.